(0.30%) 5 115.26 points
(0.25%) 38 334 points
(0.34%) 15 982 points
(-0.92%) $83.08
(5.51%) $2.03
(0.29%) $2 354.10
(0.64%) $27.71
(3.91%) $958.15
(-0.24%) $0.933
(-0.35%) $10.99
(-0.58%) $0.796
(1.67%) $93.41
@ $65.64
发出时间: 15 Feb 2024 @ 04:52
回报率: -17.38%
上一信号: Feb 14 - 22:30
上一信号:
回报率: 1.16 %
Live Chart Being Loaded With Signals
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally...
Stats | |
---|---|
今日成交量 | 131 181 |
平均成交量 | 453 556 |
市值 | 3.02B |
EPS | $0 ( 2024-02-07 ) |
下一个收益日期 | ( $0 ) 2024-05-07 |
Last Dividend | $0.100 ( 2021-12-02 ) |
Next Dividend | $0 ( N/A ) |
P/E | -169.47 |
ATR14 | $0.0490 (0.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Joseph Jason | Sell | 1 000 | Common |
2024-03-07 | Joseph Jason | Sell | 1 000 | Common |
2024-03-07 | Joseph Jason | Sell | 4 000 | Common |
2024-03-07 | Joseph Jason | Sell | 4 000 | Common |
2024-03-08 | Joseph Jason | Sell | 4 000 | Common |
INSIDER POWER |
---|
18.15 |
Last 91 transactions |
Buy: 295 223 | Sell: 171 463 |
音量 相关性
Azenta, Inc. 相关性 - 货币/商品
Azenta, Inc. 财务报表
Annual | 2023 |
营收: | $665.07M |
毛利润: | $263.14M (39.57 %) |
EPS: | $-0.220 |
FY | 2023 |
营收: | $665.07M |
毛利润: | $263.14M (39.57 %) |
EPS: | $-0.220 |
FY | 2022 |
营收: | $555.50M |
毛利润: | $255.58M (46.01 %) |
EPS: | $-0.150 |
FY | 2021 |
营收: | $513.70M |
毛利润: | $243.81M (47.46 %) |
EPS: | $1.490 |
Financial Reports:
No articles found.
Azenta, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0800 | 2011-09-07 |
Last Dividend | $0.100 | 2021-12-02 |
Next Dividend | $0 | N/A |
Payout Date | 2021-12-23 | |
Next Payout Date | N/A | |
# dividends | 42 | -- |
Total Paid Out | $3.96 | -- |
Avg. Dividend % Per Year | 0.14% | -- |
Score | 3.54 | -- |
Div. Sustainability Score | 7.91 | |
Div.Growth Potential Score | 2.49 | |
Div. Directional Score | 5.20 | -- |
Year | Amount | Yield |
---|---|---|
2011 | $0.160 | 1.74% |
2012 | $0.320 | 3.07% |
2013 | $0.320 | 3.72% |
2014 | $0.360 | 3.45% |
2015 | $0.400 | 3.17% |
2016 | $0.400 | 3.89% |
2017 | $0.400 | 2.40% |
2018 | $0.400 | 1.62% |
2019 | $0.400 | 1.53% |
2020 | $0.400 | 0.93% |
2021 | $0.400 | 0.60% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0247 | 1.500 | -0.493 | -0.740 | [0 - 0.5] |
returnOnAssetsTTM | -0.00560 | 1.200 | -0.187 | -0.224 | [0 - 0.3] |
returnOnEquityTTM | -0.00597 | 1.500 | -1.177 | -1.766 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 5.87 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 4.84 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.98 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0282 | -1.500 | 9.53 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 2 041.02 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.251 | 2.00 | 9.58 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.572 | 2.00 | 9.71 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0326 | -1.500 | 9.87 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.391 | 1.000 | 6.81 | 6.81 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.137 | 1.000 | -4.74 | -4.74 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.890 | 1.000 | 6.17 | 6.17 | [0.2 - 2] |
assetTurnoverTTM | 0.227 | 0.800 | -1.820 | -1.456 | [0.5 - 2] |
Total Score | 7.91 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -187.17 | 1.000 | -10.00 | 0 | [1 - 100] |
returnOnEquityTTM | -0.00597 | 2.50 | -0.757 | -1.766 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.572 | 2.00 | 9.81 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.251 | 2.00 | 9.58 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.297 | 1.500 | 4.69 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.111 | 1.000 | 9.73 | 0 | [0.1 - 0.5] |
Total Score | 2.49 |
Azenta, Inc.
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。